These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31812658)
1. Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men. Sarkar M; Yates K; Suzuki A; Lavine J; Gill R; Ziegler T; Terrault N; Dhindsa S Clin Gastroenterol Hepatol; 2021 Feb; 19(2):400-402.e2. PubMed ID: 31812658 [TBL] [Abstract][Full Text] [Related]
2. Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD. Sarkar MA; Suzuki A; Abdelmalek MF; Yates KP; Wilson LA; Bass NM; Gill R; Cedars M; Terrault N; Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1267-1274.e1. PubMed ID: 33010412 [TBL] [Abstract][Full Text] [Related]
3. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116 [TBL] [Abstract][Full Text] [Related]
4. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
5. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314 [TBL] [Abstract][Full Text] [Related]
6. A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesity. De Herdt C; De Block C; Francque S; Verrijken A; Van Dessel K; Van Gaal L; Van Cauwenberghe J; Dirinck E Endocrine; 2023 Apr; 80(1):54-63. PubMed ID: 36857008 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
11. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease. Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529 [TBL] [Abstract][Full Text] [Related]
12. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Guerrerio AL; Colvin RM; Schwartz AK; Molleston JP; Murray KF; Diehl A; Mohan P; Schwimmer JB; Lavine JE; Torbenson MS; Scheimann AO Am J Clin Nutr; 2012 Apr; 95(4):892-900. PubMed ID: 22338037 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111 [TBL] [Abstract][Full Text] [Related]
14. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Balakrishnan M; Patel P; Dunn-Valadez S; Dao C; Khan V; Ali H; El-Serag L; Hernaez R; Sisson A; Thrift AP; Liu Y; El-Serag HB; Kanwal F Clin Gastroenterol Hepatol; 2021 Jan; 19(1):61-71.e15. PubMed ID: 32360810 [TBL] [Abstract][Full Text] [Related]
15. Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease. Pulixi EA; Tobaldini E; Battezzati PM; D'Ingianna P; Borroni V; Fracanzani AL; Maggioni M; Pelusi S; Bulgheroni M; Zuin M; Fargion S; Montano N; Valenti L PLoS One; 2014; 9(4):e96349. PubMed ID: 24763757 [TBL] [Abstract][Full Text] [Related]
16. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Brown GT; Kleiner DE Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559 [TBL] [Abstract][Full Text] [Related]